147 related articles for article (PubMed ID: 38547690)
21. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
Yonezawa S; Nakamura A; Horinouchi M; Sato E
J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144
[TBL] [Abstract][Full Text] [Related]
22. Differential glycosylation of MUC1 in tumors and transfected epithelial and lymphoblastoid cell lines.
Poland PA; Kinlough CL; Rokaw MD; Magarian-Blander J; Finn OJ; Hughey RP
Glycoconj J; 1997 Jan; 14(1):89-96. PubMed ID: 9076518
[TBL] [Abstract][Full Text] [Related]
23. [Human mucin 1 promoter drives human sodium/iodide symporter gene targeting expression in pancreatic carcinoma cells].
Zhou QB; Chen RF; Li ZH; Pan QH; Zhou JJ; Tang QB; Chen JS
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2780-4. PubMed ID: 18167272
[TBL] [Abstract][Full Text] [Related]
24. Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain.
Kalra AV; Campbell RB
Br J Cancer; 2007 Oct; 97(7):910-8. PubMed ID: 17912239
[TBL] [Abstract][Full Text] [Related]
25. MUC1c regulates cell survival in pancreatic cancer by preventing lysosomal permeabilization.
Banerjee S; Mujumdar N; Dudeja V; Mackenzie T; Krosch TK; Sangwan V; Vickers SM; Saluja AK
PLoS One; 2012; 7(8):e43020. PubMed ID: 22912777
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis.
Besmer DM; Curry JM; Roy LD; Tinder TL; Sahraei M; Schettini J; Hwang SI; Lee YY; Gendler SJ; Mukherjee P
Cancer Res; 2011 Jul; 71(13):4432-42. PubMed ID: 21558393
[TBL] [Abstract][Full Text] [Related]
27. Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer.
Nath S; Roy LD; Grover P; Rao S; Mukherjee P
Pancreas; 2015 Aug; 44(6):909-17. PubMed ID: 26035123
[TBL] [Abstract][Full Text] [Related]
28. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.
Sahraei M; Bose M; Sanders JA; De C; DasRoy L; Nath S; Brouwer CR; Mukherjee P
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070449
[TBL] [Abstract][Full Text] [Related]
29. Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer.
Mukherjee P; Madsen CS; Ginardi AR; Tinder TL; Jacobs F; Parker J; Agrawal B; Longenecker BM; Gendler SJ
J Immunother; 2003; 26(1):47-62. PubMed ID: 12514429
[TBL] [Abstract][Full Text] [Related]
30. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas.
Wang Y; Gao J; Li Z; Jin Z; Gong Y; Man X
Int J Cancer; 2007 Dec; 121(12):2716-22. PubMed ID: 17708554
[TBL] [Abstract][Full Text] [Related]
32. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
[TBL] [Abstract][Full Text] [Related]
33. Distinct Pathogenesis of Pancreatic Cancer Microvesicle-Associated Venous Thrombosis Identifies New Antithrombotic Targets In Vivo.
Stark K; Schubert I; Joshi U; Kilani B; Hoseinpour P; Thakur M; Grünauer P; Pfeiler S; Schmidergall T; Stockhausen S; Bäumer M; Chandraratne S; von Brühl ML; Lorenz M; Coletti R; Reese S; Laitinen I; Wörmann SM; Algül H; Bruns CJ; Ware J; Mackman N; Engelmann B; Massberg S
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):772-786. PubMed ID: 29419408
[TBL] [Abstract][Full Text] [Related]
34. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells.
Tsutsumida H; Swanson BJ; Singh PK; Caffrey TC; Kitajima S; Goto M; Yonezawa S; Hollingsworth MA
Clin Cancer Res; 2006 May; 12(10):2976-87. PubMed ID: 16707592
[TBL] [Abstract][Full Text] [Related]
35. MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.
Tinder TL; Subramani DB; Basu GD; Bradley JM; Schettini J; Million A; Skaar T; Mukherjee P
J Immunol; 2008 Sep; 181(5):3116-25. PubMed ID: 18713982
[TBL] [Abstract][Full Text] [Related]
36. Dendritic cell-tumor cell fusion and staphylococcal enterotoxin B treatment in a pancreatic tumor model.
McConnell EJ; Pathangey LB; Madsen CS; Gendler SJ; Mukherjee P
J Surg Res; 2002 Oct; 107(2):196-202. PubMed ID: 12429175
[TBL] [Abstract][Full Text] [Related]
37. MUC1 regulates PDGFA expression during pancreatic cancer progression.
Sahraei M; Roy LD; Curry JM; Teresa TL; Nath S; Besmer D; Kidiyoor A; Dalia R; Gendler SJ; Mukherjee P
Oncogene; 2012 Nov; 31(47):4935-45. PubMed ID: 22266848
[TBL] [Abstract][Full Text] [Related]
38. Organ-specific pancreatic tumor growth properties and tumor immunity.
Morikane K; Tempero RM; Sivinski CL; Nomoto M; Van Lith ML; Muto T; Hollingsworth MA
Cancer Immunol Immunother; 1999 Jan; 47(5):287-96. PubMed ID: 10022473
[TBL] [Abstract][Full Text] [Related]
39. Decreased Platelet Reactivity and Function in a Mouse Model of Human Pancreatic Cancer.
Kawano T; Hisada Y; Grover SP; Schug WJ; Paul DS; Bergmeier W; Mackman N
Thromb Haemost; 2023 May; 123(5):501-509. PubMed ID: 36716775
[TBL] [Abstract][Full Text] [Related]
40. A study on the antitumor effect of gemcitabine polybutylcy- anoacrylate nanoparticles coupled with Mucin 1 monoclonal antibody on pancreatic cancer
Zhang L; Zhu J; Hou Y; Li C; Liu H
J Cancer Res Ther; 2021 Dec; 17(7):1702-1708. PubMed ID: 35381742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
